Markets:

Overview

News

Currencies

International

Treasuries

Avidity Biosciences, Inc. - Common Stock (NQ:RNA)

70.85 UNCHANGED

Streaming Delayed Price Updated: 4:00 PM EST, Nov 18, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Avidity Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025

November 14, 2025

The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in...

Via MarketMinute

Here's Why Avidity Biosciences Stock Soared This Week (There's More to the Deal Than You Might Think) ↗

October 31, 2025

Novartis is set to boost its developmental pipeline with this acquisition.

Via The Motley Fool

Unusual volume stocks in Thursday's session ↗

October 30, 2025

Discover the stocks with unexpected trading volume in today's session on the US markets.

Via Chartmill

Dyne Therapeutics Stock Soars After Rival Avidity Biosciences Gets Acquired By Novartis ↗

October 27, 2025

Via Stocktwits

Dow Futures Rise As China Trade Tensions Ease: NVDA, MP, BA, RNA Among Stocks To Watch ↗

October 27, 2025

Via Stocktwits

Topics Stocks World Trade

$1000 Invested In Avidity Biosciences 5 Years Ago Would Be Worth This Much Today ↗

October 29, 2025

Via Benzinga

Nucor To Rally More Than 14%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

October 28, 2025

Via Benzinga

This Boot Barn Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday ↗

October 28, 2025

Via Benzinga

Novartis Maintains Outlook Even As Generics Bite Into Profits ↗

October 28, 2025

Novartis Q3 sales rose 8% to $13.91 billion, missing estimates, as Kisqali and Kesimpta drove growth while U.S. generics weighed on results.

Via Benzinga

'Merger Monday' Makes Comeback As US M&A Tops $80 Billion In 24 Hours ↗

October 28, 2025

U.S. companies have struck more than $80 billion worth of deals in the past 24 hours, in the latest sign that mergers and acquisitions (M&A) are picking up after the tariff-induced cool-off earlier...

Via Benzinga

Wall Street Soars as Qualcomm Ignites the AI Race ↗

October 27, 2025

Investor optimism drives the S&P 500 to new records while Qualcomm steals the spotlight with an 11% surge after unveiling new AI chips.

Via Chartmill

Topics Artificial Intelligence Stocks

Why Avidity Biosciences Stock Blasted 42% Higher Today ↗

October 27, 2025

If all goes well, the company will be part of a much larger enterprise starting next year.

Via The Motley Fool

Which stocks are moving on Monday? ↗

October 27, 2025

Looking for insights into the US markets one hour before the close of the markets on Monday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.

Via Chartmill

Avidity Biosciences Soars After $72 Per Share Novartis Takeover ↗

October 27, 2025

Avidity Biosciences (RNA) to be acquired by Novartis in a $12 billion cash deal. H.C. Wainwright downgrades to Neutral.

Via Benzinga

Qualcomm, Tesla, Intellia Therapeutics, Avidity Biosciences, Dyne Therapeutics: Stocks Making The Biggest Moves Today ↗

October 27, 2025

Qualcomm shares were up more than 11% in Monday’s midday session after the company unveiled two AI accelerator chips.

Via Stocktwits

Topics Artificial Intelligence ETFs Government

Keep an eye on the top gainers and losers in Monday's session. ↗

October 27, 2025

Let's have a look at what is happening on the US markets in the middle of the day on Monday. Below you can find the top gainers and losers in today's session.

Via Chartmill

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 27, 2025

Via Benzinga

Which stocks are gapping on Monday? ↗

October 27, 2025

The session on Monday is off to an intriguing start with several stocks showing significant price gaps. Let's examine the gap up and gap down stocks in today's session.

Via Chartmill

Janus Henderson, Avidity Biosciences, BridgeBio Pharma And Other Big Stocks Moving Higher On Monday ↗

October 27, 2025

Via Benzinga

These stocks are moving in today's pre-market session ↗

October 27, 2025

Before the US market kicks off on Monday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Via Chartmill

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 27, 2025

Via Benzinga

Booking Holdings To Rally Around 12%? Here Are 10 Top Analyst Forecasts For Monday ↗

October 27, 2025

Via Benzinga

This Harley-Davidson Analyst Turns Bearish; Here Are Top 5 Downgrades For Monday ↗

October 27, 2025

Via Benzinga

Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal ↗

October 27, 2025

Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash.

Via Benzinga

Why Avidity Biosciences Stock Is Jumping Over 43% In Premarket Today ↗

October 27, 2025

Novartis has agreed to buy Avidity Biosciences in a deal valued at $72 per share.

Via Stocktwits

Stock Market Today: Dow Jones, S&P 500 Futures Climb Ahead Of Busy Week On Wall Street—Novartis, Nucor, Waste Management In Focus ↗

October 27, 2025

U.S. stock futures rose on Monday following Friday’s positive moves. Futures of major benchmark indices were higher.

Via Benzinga

Topics Stocks

Why Avidity Biosciences Shares Are Trading Higher By Around 42%; Here Are 20 Stocks Moving Premarket ↗

October 27, 2025

Via Benzinga

Is Avidity Biosciences Inc Gaining or Losing Market Support? ↗

October 22, 2025

Via Benzinga

Looking Into Avidity Biosciences's Recent Short Interest ↗

September 23, 2025

Via Benzinga

Crude Oil Rises 1%; Manufacturing Activity in New York Falls In September ↗

September 15, 2025

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Avidity Biosciences, Inc. - Common Stock (NQ:RNA)

Headline News about Avidity Biosciences, Inc. - Common Stock

Starting at $3.75/week.

Subscribe Today